GoodRx (GDRX) Erupts 40% on Mixed Results but Analysts Praise Better Visibility

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MCD
7. MGM
8. NVDA
9. AKAM
10. ACAD

Go back to GoodRx (GDRX) Erupts 40% on Mixed Results but Analysts Praise Better Visibility

GoodRx Holdings Inc. (GDRX) PT Raised to $11 at RBC Capital

August 9, 2022 6:19 AM EDT

RBC Capital analyst Mark Mahaney raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $11.00 (from $6.50) while maintaining a Sector Perform rating.... More

GoodRx Holdings Inc. (GDRX) PT Raised to $13 at Barclays

August 9, 2022 5:33 AM EDT

Barclays analyst Ross Sandler raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $13.00 (from $12.00) while maintaining a Overweight rating.... More

GoodRx Holdings Inc. (GDRX) PT Raised to $10 at JPMorgan

August 9, 2022 4:14 AM EDT

JPMorgan analyst Doug Anmuth raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $10.00 (from $7.00) while maintaining a Underweight rating.... More

GoodRx Holdings Inc. (GDRX) PT Raised to $11 at Credit Suisse

August 9, 2022 3:29 AM EDT

Credit Suisse analyst Jonathan Yong raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $11.00 (from $10.00) while maintaining a Neutral rating.... More

GoodRx Holdings Inc. (GDRX) PT Raised to $12 at Evercore ISI

August 9, 2022 3:18 AM EDT

Evercore ISI analyst Mark Mahaney raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $12.00 (from $10.00) while maintaining a In Line rating.... More